Our technology involves the engineering and fabrication of erythrocyte-derived vesicles with tunable diameters and containing appropriate formulations of probes for image-guided therapeutics of solid cancers and vascular diseases on an individual patient basis.
• RBC-based nano and micro particles
• Ease of custom targeting various cancer biomarkers
• Platform for combined chemo- and photo-therapeutics
In relation to cancer imaging and therapy, Radoptics technologies can provide a capability for image-guided surgical removal of small tumor nodules that are not otherwise visually detectable during surgery, or pre-operatively by current imaging methods, and mediate destruction of tumor cells through a combination of chemotherapy and pulsed near infrared thermal therapy.